Safety and Efficacy of Interferon Gamma-1b Plus Chemotherapy for Ovarian and Peritoneal Cancer
Status:
Terminated
Trial end date:
2006-02-01
Target enrollment:
Participant gender:
Summary
The purposes of this study are to determine: 1) if treatment with interferon gamma-1b plus
standard chemotherapy (carboplatin and paclitaxel) can increase the overall survival of
patients with advanced ovarian or primary peritoneal carcinoma compared with chemotherapy
alone; 2) how effective interferon gamma-1b plus standard chemotherapy is in preventing the
progression or return of cancer; 3) the effects on quality of life; and 4) the safety of
interferon gamma-1b combined with standard chemotherapy compared to chemotherapy alone.